Dose-dependent inhibitory effect of melatonin on carcinogenesis induced by benzo[a]pyrene in mice

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 4, 2006, Pages 507-513

  Vesnushkin, G M ^a   Plotnikova, N A ^a   Semenchenko, A I ^b   Anisimov, V N ^b,c  

^a OGAREV MORDOVIA STATE UNIVERSITY   (Russian Federation)

^b N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^c NONE   (Russian Federation)

Author keywords

Benzo a pyrene; Carcinogenesis; Melatonin; Mice; Subcutaneous sarcoma

Indexed keywords

BENZO[A]PYRENE; CATALASE; MALONALDEHYDE; MELATONIN;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST DISEASE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; ENZYME ACTIVITY; LIPID BLOOD LEVEL; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; RAT; SARCOMA; SQUAMOUS CELL CARCINOMA; SURVIVAL; TUMOR VOLUME;

AGING; ANIMALS; AUTOPSY; BENZO(A)PYRENE; CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LIPID PEROXIDATION; MALONDIALDEHYDE; MELATONIN; MICE; NEOPLASMS, EXPERIMENTAL; RATS; SKIN;

EID: 33846486099     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Claustrat B., Brun J., Chazot G.: The basic physiology and pathophysiology of melatonin. Sleep Med. Rev. 45: 11-24, 2005.
2. Komarov F.I., Rapoport S.I., Malinovskaya N.K., Anisimov V.N.: Melatonin in Norm and Pathology. Moscow Publ House Medpraktika, 2004.
3. Anisimov S.V., Popovic N.: Genetic analysis of melatonin biology. Rev. Neurosci. 15: 209-230, 2004.
4. Anisimov S.V., Boheler K.R., Anisimov V.N.: Microarray technology in studying the effect of melatonin on gene expression in the mouse heart. Dokl. Biol. Sci. 383: 90-95, 2002.
5. Aubert C., Janiaud P., Lecalvez J.: Effect of pinealectomy and melatonin on mammary tumor growth in Sprague-Dawley rats under different conditions of lighting. J. Neural Transmiss. 47: 121-130, 1980.
6. Anisimov V.N.: Effects of exogenous melatonin - a review. Toxicol. Pathol. 31: 589-603, 2003.
7. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke D. (Eds). The Pineal Gland and Cancer. Neuroimmunoendocrine Mechanisms in Malignancy. Berlin Springer, 2001.
8. Blask D.E., Pelletier D.B., Hill S.M., et al.: Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo. J. Cancer Res. Clin. Oncol. 117: 526-532, 1991.
9. Anisimov V.N., Popovich I.G., Zabezhinski M.A.: Melatonin and colon carcinogenesis: I. Inhibitory effects of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. Carcinogenesis 18: 1549-1553, 1997.
10. Musatov S.V., Anisimov V.N., Andre V., et al.: Effects of melatonin on N-nitroso-N-methylurea-induced carcinogenesis in rats and mutagenesis in vitro (Ames test and COMET assay). Cancer Lett. 138: 37-44, 1999.
11. Kothari L.: Effect of melatonin on the mammary gland morphology, DNA synthesis, hormone profiles and incidence of mammary cancer in rats. In: The Pineal Gland and Cancer. Gupta D., Attanasio A., Reiter R.J., eds. London: Brain Research Promotion, 1988:210-219.
12. Kumar C.A., Das U.: Effect of melatonin on two stage skin carcinogenesis in Swiss mice. Med. Sci. Monit. 6.: 461-475, 2000.
13. Lenoir V., de Jonage-Canonico M.B.Y., Perrin M.-H., et al.: Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague-Dawley rat. Breast Cancer Res. 7: R470-R476, 2005.
14. Melancon K., Cheng Q., Kiefer T.L., et al.: Regression of NMU-induced mammary tumors with the combination of melatonin and 9-cis-retinoic acid. Cancer Lett. 227: 29-48, 2005.
15. Cos S., Sanchez-Barcelo E.J.: Melatonin and mammary pathological growth. Front. Neuroendocrin. 17/: 133-170, 2000.
16. Anisimov V.N., Alimova I.N., Baturin D.A., et al.: The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice. Int. J. Cancer 103: 300-305, 2003.
17. Konyukhova S.G., Dubrikaitis A.Y., Shabunovich L.V.: The role of the activation of lipid peroxidation in the pathogenesis of experimental peritonitis. Bull. Exp. Biol. Med. 107: 557-559, 1989.
18. Korolyuk M.A., Ivanova L.I., Majorova I.G., Tokarev V.E.: Estimation of catalase activity. Lab. Delo 1: 16-19, 1988.
19. Turusov V.S., Mohr U. (Eds): Pathology of Tumours in Laboratory Animals. Volume I. Tumours of the Mouse. 2nd ed. IARC Sci Publ No 111. Lyon IARC, 1994.
20. Gompertz B.: On the nature of the function expressive of the law of human mortality, and on the new mode of determining the values of life contingencies. Philosophical Transaction, The Royal Soc.(London) 115: 513-585, 1825.
21. Fletcher R.: Practical methods of optimization. New York John Wiley & Sonh, 2nd ed., 1987.
22. Davison A.C., Hinkley D.V.: Bootstrap Methods and Their Application. Cambridge, England, Cambridge, England, Cambridge University Press, 1997.
23. Vijayalaxmi, Thomas C.R., Reiter R.J., Herman T.S.L.: Melatonin: from basic research to cancer treatment clinic. J. Clin. Oncol. 20: 2575-2601, 2002.
24. Anisimov V.N., Alimova I.N., Baturin D.A., et al.: Dose-dependent effect of melatonin on life span and spontaneous tumor incidence in female SHR mice. Exp. Gerontol. 38: 449-461, 2003.
25. Subramanian A., Kothari L.: Melatonin, a suppressor of spontaneous murine mammary tumors. J. Pineal Res. 10: 136-140, 1991.
26. Mediavilla M.D., Guezmez A., Ramos S., Kothari L., Garijo F., Sanchez-Barcelo E.J.: Effect of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras protooncogene. J. Pineal. Res. 22: 86-94, 1997.
27. Rao G.N., Ney E., Herbert R.A.: Effect of melatonin and linolenic acid on mammary cancer in transgenic mice with c-neu breast cancer oncogene. Breast Cancer Res. Treatment 64: 287-296, 2000.
28. Baturin D.A., Alimova I.N., Anisimov V.N., et al.: Effect of light regime and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. Neuroendocr. Lett. 22: 439-445, 2001.
29. Anisimov V.N., Zabezhinski M.A., Popovich I.G., et al.: Inhibitory effect of melatonin on 7,12-dimethylbenz[a]anthracene-induced carcinogenesis of the uterine cervix and vagina in mice and mutagenesis in vitro. Cancer Lett. 156:199-205, 2000.
30. Weisburger J.H., Rivenson A., Choi C.I., Reinhardt J., Pittman B., Zang E.: Inhibition of lung, mammary gland and colon tumors by melatonin. Proc. Am. Assoc. Cancer. Res., Abstract #5694; 44 (2nd ed): 1133-1134, 2003.
31. Vesnushkin G.M., Plotnikova N.A., Semenchenko A.V., Anisimov V.N.: Melatonin inhibits lung carcinogenesis induced by urethane in mice. Vopr. Onkol. 52: 164-168, 2006.
32. Lazarev N.I., Ird E.I., Smirnova I.O.: Experimental Models of Endocrine Gynecological Diseases. Moscow Meditsina, 1976.
33. Shah P.N., Mhatre M.C., Kothari L.: Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res. 44: 3403-3407, 1984.
34. Tamarkin L., Cohen D., Roselle C., Reichert M.: Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat. Cancer Res. 41: 4432-4436, 1981.
35. Mockova K., Mnichova M., Kubatka P., Bojkova B., Ahlers I., Ahlersova E.: Mammary carcinogenesis induced in Wistar: Han rats by the combination of ionizing radiation and dimethylbenz(a)anthracene: prevention with melatonin. Neoplasma 47: 227-229, 2000.
36. Deerberg F., Bartsch C., Pohlmeyer G., Bartsch H.: Effect of melatonin and physiological epiphysectomy on the development of spontaneous endometrial carcinoma in BDII/HAN rats. Cancer Biother. Radiopharmacol. 12: 420, 1997.
37. Musatov S.A., Anisimov V.N., Andre V., et al.: Modulatory effects of melatonin on genotoxic response of reference mutagens in the Ames test and the comet assay. Mutat. Res. 417: 75-84, 1998.
38. Kothari L., Subramanian A.: A possible modulatory influence of melatonin on representative phase I and II drug metabolizing enzymes in 9,10-dimethyl-benzanthracene induced rat mammary tumorigenesis. Anticancer Drugs 3: 623-628, 1992.
39. Anisimov VN. Melatonin and colon carcinogenesis. In: The Pineal Gland and Cancer. Bartsch C., Bartsch H., Blask D., Cardinali D.P., Hrushesky W.J.M., Mecke D. (Eds). The Pineal Gland and Cancer. Neuroimmunoendocrine Mechanisms in Malignancy. Berlin Springer, 2001: 240-258.
40. Lehner A.F., Horn J., Flesher J.W.: Formation of radical cations in a model for the metabolism of aromatic hydrocarbons. Biochem. Biophys. Res. Commun. 322: 1018-1023, 2004.
41. Klaunig J.E., Kamendulis L.M.: The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 44: 239-267, 2004.
42. Tamimi R.M., Lagiou P., Adami H.O., Trichopoulos D.: Prospects for chemoprevention of cancer. J. Intern. Med. 251: 286-300, 2002.